Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.34% | 74.35 | 0.0% | $2403.57m | |
| NVAX | Novavax, Inc. | 3.41% | 176.10 | 99.2% | $1260.45m | |
| SRNE | Sorrento Therapeutics, Inc. | 8.95% | 15.71 | 1.8% | $652.23m | |
| GILD | Gilead Sciences, Inc. | -0.40% | 69.07 | 1.0% | $556.88m | |
| AMGN | Amgen, Inc. | -0.08% | 240.50 | 1.3% | $476.23m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.36% | 618.00 | 2.5% | $427.98m | |
| BNTX | BioNTech SE | 1.30% | 78.00 | 0.0% | $404.75m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.00% | 272.99 | 1.9% | $368.45m | |
| BIIB | Biogen, Inc. | 0.91% | 308.50 | 1.6% | $364.36m | |
| ILMN | Illumina, Inc. | 0.38% | 357.01 | 3.5% | $338.10m | |
| VXRT | Vaxart, Inc. | 2.29% | 9.40 | 0.0% | $287.41m | |
| EBS | Emergent BioSolutions, Inc. | 0.00% | 130.66 | 6.4% | $180.62m | |
| IBIO | iBio, Inc. | 10.82% | 4.20 | 0.2% | $175.66m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.11% | 103.17 | 2.0% | $166.42m | |
| SGEN | Seattle Genetics, Inc. | -0.83% | 160.45 | 6.0% | $163.01m |
Company Profile
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.